Total Funding
30
64
Total FundingPre-Seed raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
141948
Caren Pharma develops hormone-based therapeutics targeting aging, Alzheimer’s, and other age-related diseases.
- David Friedman: Co-Founder
- Edward Friedman: Co-FounderPast Role: University of Chicago, Computer Coordinator
About the Company
Caren Pharma is a pharmaceutical company developing hormone-based therapeutics for Alzheimer’s and other age-related diseases. By repurposing and reformulating known agents to target a novel pathway, Caren Pharma aims to accelerate development timelines and deliver innovative treatments that enhance longevity and significantly improve patient
outcomes.
